Current protocol approaches in large bowel cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002330:Carmustine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D003606:Dacarbazine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008937:Mitomycins / Q000627:therapeutic use; D010919:Placebos; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D012673:Semustine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D008937:Mitomycins; D010919:Placebos; D012673:Semustine; D003606:Dacarbazine; D005472:Fluorouracil; D002330:Carmustine